EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population

Laurence J Dobbie iD, Claudia Coelho, Farah Mgaieth, Keisha Chauhan, Scott Campbell, Sumaya Shuriye, Joanna Hollington, Sarah Appleton, Piya Sen Gupta, Alastair Duncan, Barbara McGowan iD

Clinical Obesity · 2024

DOI: 10.1111/cob.12649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Obesity, 2024. Verfasst von Laurence J Dobbie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Liraglutide, Prediabetic State, Obesity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

UK guidelines recommend liraglutide 3.0 mg in adults treated within specialist weight management services with BMI ≥35 kg/m 2 , prediabetes and high cardiovascular disease risk. We aimed to clinically evaluate liraglutide 3.0 mg in specialist weight management services. We evaluated liraglutide 3.0 mg in weight management services at Guys and St Thomas' NHS Foundation Trust. Objective body weight (BW) was measured at baseline and 4 months, allowing classification as ‘responders’ (≥5% BW reduction) and ‘non‐responders’ (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutidePrediabetic StateObesityHumansFemaleMaleMiddle AgedUnited KingdomAdultHypoglycemic AgentsWeight LossTreatment OutcomeBody Mass IndexEthnicityAged

Stichwörter der Autor:innen

GLP‐1 receptor agonistsethnicityobesitypharmacotherapytotal‐meal replacement

Substanzen

LiraglutideHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Department of Nutrition and Dietetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.

ORCID-Profile: Laurence J Dobbie, Barbara McGowan

Zitieren

APA

Dobbie, L. J., Coelho, C., Mgaieth, F., Chauhan, K., Campbell, S., Shuriye, S., Hollington, J., Appleton, S., Sen Gupta, P., Duncan, A., & McGowan, B. (2024). Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population. Clinical Obesity. https://doi.org/10.1111/cob.12649

Vancouver

Dobbie LJ, Coelho C, Mgaieth F, Chauhan K, Campbell S, Shuriye S, et al. Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population. Clinical Obesity. 2024. doi:10.1111/cob.12649

BibTeX
@article{Dobbie2024,
  author = {Dobbie, Laurence J and Coelho, Claudia and Mgaieth, Farah and Chauhan, Keisha and Campbell, Scott and Shuriye, Sumaya and Hollington, Joanna and Appleton, Sarah and Sen Gupta, Piya and Duncan, Alastair and McGowan, Barbara},
  title = {Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population},
  journal = {Clinical Obesity},
  year = {2024},
  doi = {10.1111/cob.12649}
}
Kostenlos starten →